Cargando…

Targeting Drug Chemo-Resistance in Cancer Using Natural Products

Cancer is one of the leading causes of death globally. The development of drug resistance is the main contributor to cancer-related mortality. Cancer cells exploit multiple mechanisms to reduce the therapeutic effects of anticancer drugs, thereby causing chemotherapy failure. Natural products are ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Talib, Wamidh H., Alsayed, Ahmad Riyad, Barakat, Muna, Abu-Taha, May Ibrahim, Mahmod, Asma Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533186/
https://www.ncbi.nlm.nih.gov/pubmed/34680470
http://dx.doi.org/10.3390/biomedicines9101353
_version_ 1784587250849284096
author Talib, Wamidh H.
Alsayed, Ahmad Riyad
Barakat, Muna
Abu-Taha, May Ibrahim
Mahmod, Asma Ismail
author_facet Talib, Wamidh H.
Alsayed, Ahmad Riyad
Barakat, Muna
Abu-Taha, May Ibrahim
Mahmod, Asma Ismail
author_sort Talib, Wamidh H.
collection PubMed
description Cancer is one of the leading causes of death globally. The development of drug resistance is the main contributor to cancer-related mortality. Cancer cells exploit multiple mechanisms to reduce the therapeutic effects of anticancer drugs, thereby causing chemotherapy failure. Natural products are accessible, inexpensive, and less toxic sources of chemotherapeutic agents. Additionally, they have multiple mechanisms of action to inhibit various targets involved in the development of drug resistance. In this review, we have summarized the basic research and clinical applications of natural products as possible inhibitors for drug resistance in cancer. The molecular targets and the mechanisms of action of each natural product are also explained. Diverse drug resistance biomarkers were sensitive to natural products. P-glycoprotein and breast cancer resistance protein can be targeted by a large number of natural products. On the other hand, protein kinase C and topoisomerases were less sensitive to most of the studied natural products. The studies discussed in this review will provide a solid ground for scientists to explore the possible use of natural products in combination anticancer therapies to overcome drug resistance by targeting multiple drug resistance mechanisms.
format Online
Article
Text
id pubmed-8533186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85331862021-10-23 Targeting Drug Chemo-Resistance in Cancer Using Natural Products Talib, Wamidh H. Alsayed, Ahmad Riyad Barakat, Muna Abu-Taha, May Ibrahim Mahmod, Asma Ismail Biomedicines Review Cancer is one of the leading causes of death globally. The development of drug resistance is the main contributor to cancer-related mortality. Cancer cells exploit multiple mechanisms to reduce the therapeutic effects of anticancer drugs, thereby causing chemotherapy failure. Natural products are accessible, inexpensive, and less toxic sources of chemotherapeutic agents. Additionally, they have multiple mechanisms of action to inhibit various targets involved in the development of drug resistance. In this review, we have summarized the basic research and clinical applications of natural products as possible inhibitors for drug resistance in cancer. The molecular targets and the mechanisms of action of each natural product are also explained. Diverse drug resistance biomarkers were sensitive to natural products. P-glycoprotein and breast cancer resistance protein can be targeted by a large number of natural products. On the other hand, protein kinase C and topoisomerases were less sensitive to most of the studied natural products. The studies discussed in this review will provide a solid ground for scientists to explore the possible use of natural products in combination anticancer therapies to overcome drug resistance by targeting multiple drug resistance mechanisms. MDPI 2021-09-29 /pmc/articles/PMC8533186/ /pubmed/34680470 http://dx.doi.org/10.3390/biomedicines9101353 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Talib, Wamidh H.
Alsayed, Ahmad Riyad
Barakat, Muna
Abu-Taha, May Ibrahim
Mahmod, Asma Ismail
Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title_full Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title_fullStr Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title_full_unstemmed Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title_short Targeting Drug Chemo-Resistance in Cancer Using Natural Products
title_sort targeting drug chemo-resistance in cancer using natural products
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533186/
https://www.ncbi.nlm.nih.gov/pubmed/34680470
http://dx.doi.org/10.3390/biomedicines9101353
work_keys_str_mv AT talibwamidhh targetingdrugchemoresistanceincancerusingnaturalproducts
AT alsayedahmadriyad targetingdrugchemoresistanceincancerusingnaturalproducts
AT barakatmuna targetingdrugchemoresistanceincancerusingnaturalproducts
AT abutahamayibrahim targetingdrugchemoresistanceincancerusingnaturalproducts
AT mahmodasmaismail targetingdrugchemoresistanceincancerusingnaturalproducts